Trial Profile
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary) ; Testosterone
- Indications Hypogonadism
- Focus Adverse reactions
- Sponsors Clarus Therapeutics
- 05 Oct 2018 Status changed from active, no longer recruiting to completed.
- 21 Nov 2014 New trial record